WHI
ZVRA icon

William Harris Investors’s Zevra Therapeutics ZVRA Stock Holding History

William Harris Investors’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$35K Sell
744
-1,187
-61% -$72.9K 0.01% 94
2016
Q3 		$139K Hold
1,931
– – 0.04% 83
2016
Q2 		$123K Buy
1,931
+932
+93% +$153K 0.03% 89
2016
Q1 		$232K Buy
+999
New +$242K 0.06% 79

Other funds holding ZVRA

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
PL
Parkwood LLC Cleveland, Ohio $1.4B AUM 33.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Harris Investors's ZVRA Position: Q4 2016 in Review

William Harris Investors reduced its Zevra Therapeutics (ZVRA) stake by 61% in Q4 2016, selling an estimated $72.9K and leaving 744 shares worth $35K. The position accounts for 0.01% of the portfolio, ranked #94.

William Harris Investors first reported a position in ZVRA in Q1 2016 and has held it in 4 quarters since. The position peaked at $232K in Q1 2016. 36 funds tracked by Wall St. Rank hold ZVRA as of Q4 2016.

  • William Harris Investors held 744 shares of Zevra Therapeutics worth $35K as of Q4 2016.
  • William Harris Investors sold 1,187 Zevra Therapeutics shares in Q4 2016, an estimated $72.9K.
  • Zevra Therapeutics made up 0.01% of William Harris Investors's portfolio in Q4 2016, its #94 holding.
  • William Harris Investors first reported a position in Zevra Therapeutics in Q1 2016 and has held it in 4 quarters since.
  • William Harris Investors's Zevra Therapeutics position peaked at $232K in Q1 2016.
  • 36 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q4 2016.

Based on William Harris Investors's 13F filing for Q4 2016, filed 7 Feb 2017.